Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Rights and permissions
About this article
Cite this article
Länger progressionsfrei unter Axitinib. Info Onkol. 14, 67 (2011). https://doi.org/10.1007/BF03363062
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03363062